Frangoul, H., Hanna, R., Walters, M. C., Kao, R. L., Carroll, C., McManus, M., Chang, K., Jaskolka, M. C., Kim, K., Yu, Q., Badamosi, N., Mei, B., Afonja, O., Thompson, A. (2026). CRISPR-Cas12a Gene Editing of
                    <i>HBG1</i>
                    and
                    <i>HBG2</i>
                    Promoters to Treat β-Thalassemia. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2501277